Harte Hanks (HHS) EBIT (2010 - 2026)

Harte Hanks (HHS) has 17 years of EBIT data on file, last reported at -$768000.0 in Q1 2026.

• On a quarterly basis, EBIT fell 1820.0% year-over-year to -$768000.0 in Q1 2026; TTM through Mar 2026 was -$342000.0, a 120.38% decrease from a year earlier, with the FY2025 full-year figure at $386000.0, down 81.56% from the prior year.
• EBIT for Q1 2026 stood at -$768000.0, down from -$117000.0 in the prior quarter.
• Over the last five years, EBIT for HHS reached as high as $4.0 million in Q2 2022 and fell as low as -$2.3 million in Q4 2023.
• Historically, EBIT has averaged $1.2 million across 5 years, with a median of $1.1 million in 2023.
• Across the five-year window, EBIT jumped 540.5% in 2022 and sank 1820.0% in 2026, its largest moves.
• Year by year, EBIT stood at $3.4 million in 2022, then slumped by 166.43% to -$2.3 million in 2023, then jumped by 31.83% to -$1.6 million in 2024, then jumped by 92.47% to -$117000.0 in 2025, then sank by 556.41% to -$768000.0 in 2026.
• Per Business Quant data, the three most recent EBIT figures were -$768000.0 in Q1 2026, -$117000.0 in Q4 2025, and $509000.0 in Q3 2025.